Literature DB >> 27542883

Diagnosis and Treatment of Insomnia Comorbid with Obstructive Sleep Apnea.

Leon Lack1, Alexander Sweetman2.   

Abstract

Insomnia is often comorbid with obstructive sleep apnea. It reduces positive airway pressure (PAP) therapy acceptance and adherence. Comorbid patients show greater daytime impairments and poorer health outcomes. The insomnia often goes undiagnosed, undertreated, or untreated. Pharmacotherapy is not recommended for long-term treatment. Although care should be taken administering behavioral therapies to patients with elevated sleepiness, cognitive behavior therapy for insomnia (CBTi) is an effective and durable nondrug therapy that reduces symptoms and may increase the effectiveness of PAP therapy. Sleep clinics should be alert to comorbid insomnia and provide adequate diagnostic tools and clinicians with CBTi expertise.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBTi; Comorbid insomnia; Nondrug insomnia treatment; OSA; PAP adherence; PAP therapy

Mesh:

Year:  2016        PMID: 27542883     DOI: 10.1016/j.jsmc.2016.05.006

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  13 in total

Review 1.  Sleep and Sleep Disorders in the Menopausal Transition.

Authors:  Fiona C Baker; Laura Lampio; Tarja Saaresranta; Päivi Polo-Kantola
Journal:  Sleep Med Clin       Date:  2018-09

2.  The Role of Dentists in the Diagnosis and Treatment of Obstructive Sleep Apnea: Consensus and Controversy.

Authors:  Stuart F Quan; Wolfgang Schmidt-Nowara
Journal:  J Clin Sleep Med       Date:  2017-10-15       Impact factor: 4.062

3.  Refining the Measurement of Insomnia in Patients With Obstructive Sleep Apnea.

Authors:  Alexander Sweetman; Leon Lack; Doug McEvoy
Journal:  J Clin Sleep Med       Date:  2019-11-02       Impact factor: 4.062

4.  Early objective adherence to hypoglossal nerve stimulation therapy.

Authors:  Phillip Huyett
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

Review 5.  Sleep Deficiency in Obstructive Sleep Apnea.

Authors:  Olurotimi Adekolu; Andrey Zinchuk
Journal:  Clin Chest Med       Date:  2022-06       Impact factor: 4.967

6.  The reproducibility of clinical OSA subtypes: a population-based longitudinal study.

Authors:  Priscila Farias Tempaku; Luciana Oliveira E Silva; Thaís Moura Guimarães; Tatiana de Aguiar Vidigal; Vânia D'Almeida; Monica Levy Andersen; Lia Bittencourt; Sergio Tufik
Journal:  Sleep Breath       Date:  2022-01-05       Impact factor: 2.655

7.  Comorbid Insomnia With Obstructive Sleep Apnea: Clinical Characteristics and Risk Factors.

Authors:  Yong Won Cho; Keun Tae Kim; Hye-Jin Moon; Valeriy R Korostyshevskiy; Gholam K Motamedi; Kwang Ik Yang
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

8.  Comorbid insomnia symptoms predict lower 6-month adherence to CPAP in US veterans with obstructive sleep apnea.

Authors:  Douglas M Wallace; A M Sawyer; S Shafazand
Journal:  Sleep Breath       Date:  2018-01-04       Impact factor: 2.816

Review 9.  Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies.

Authors:  Renae C Fernandez; Vivienne M Moore; Emer M Van Ryswyk; Tamara J Varcoe; Raymond J Rodgers; Wendy A March; Lisa J Moran; Jodie C Avery; R Doug McEvoy; Michael J Davies
Journal:  Nat Sci Sleep       Date:  2018-02-01

10.  Combination of obstructive sleep apnoea and insomnia treated by continuous positive airway pressure with the SensAwake pressure relief technology to assist sleep: a randomised cross-over trial protocol.

Authors:  Jean Louis Pepin; Frédéric Gagnadoux; Alison Foote; Rachel Vicars; Bhavi Ogra; Véronique Viot-Blanc; Meriem Benmerad; Marie-Pia D'Ortho; Renaud Tamisier
Journal:  BMJ Open       Date:  2017-10-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.